An engineered TGF-β monomer that functions as a dominant negative to block TGF-β signaling

From National Research Council Canada

Download
  1. (PDF, 3 MB)
DOIResolve DOI: https://doi.org/10.1074/jbc.M116.768754
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1 ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleJournal of Biological Chemistry
ISSN0021-9258
1083-351X
Pages# of pages: 40
Abstract
Publication date
PublisherAmerican Society for Biochemistry and Molecular Biology
Terms of use
LanguageEnglish
Peer reviewedYes
NPARC number23002201
Export citationExport as RIS
Report a correctionReport a correction
Record identifier7fa45627-206c-465e-8616-06acc30fe7e8
Record created2017-09-05
Record modified2019-03-11
Date modified: